Equities

Koa Shoji Holdings Co Ltd

9273:TYO

Koa Shoji Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)869.00
  • Today's Change0.00 / 0.00%
  • Shares traded15.10k
  • 1 Year change+21.54%
  • Beta0.8408
Data delayed at least 20 minutes, as of May 24 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KOA SHOJI HOLDINGS CO., LTD. is engaged in purchasing and sales of drug substance, manufacturing, purchasing and sales of pharmaceuticals, including medical prescription drugs and general pharmaceutical products, as well as contract manufacturing of formulation of pharmaceuticals. The Company operates through two business segments. The pharmaceutical manufacturing and sales business is engaged in development, manufacturing, contract manufacturing and sales of generic injection, oral preparation and external preparation. The drug substance sales business is engaged in import and export of generic drug raw materials, as well as introducing and supply of pharmaceutical raw materials and preparations.

  • Revenue in JPY (TTM)22.67bn
  • Net income in JPY2.87bn
  • Incorporated2015
  • Employees297.00
  • Location
    Koa Shoji Holdings Co Ltd7-13-15, Hiyoshi, Kohoku-kuYOKOHAMA-SHI 223-0061JapanJPN
  • Phone+81 455606607
  • Websitehttps://www.koashoji-hd.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TAIKO PHARMACEUTICAL CO LTD6.33bn-2.90bn18.84bn208.00--2.51--2.98-58.49-58.49129.20148.040.4622.043.4430,432,690.00-21.14---26.00--44.27---45.75--2.92--0.2811--21.43--26.23------
Medical Data Vision Co Ltd6.25bn688.02m19.33bn262.0026.824.6325.573.0918.0118.01163.57104.341.15282.077.8423,847,790.0012.1816.1617.0120.8877.4381.9010.5515.522.7213.480.0019.985.1512.4012.4869.75-23.95--
Astena Holdings Co Ltd52.63bn1.62bn20.08bn1.40k11.960.67825.220.381640.9840.981,332.61722.460.81273.312.7637,482,540.002.492.494.444.4432.2725.333.062.320.8713--0.351744.924.73-2.85100.61-3.8538.5411.38
Fuso Pharmaceutical Industries Ltd55.41bn1.38bn21.60bn1.31k14.300.53267.530.3898159.77159.776,435.264,290.490.74743.122.43--1.861.913.063.0924.9826.922.492.691.0454.560.257641.178.613.76-14.219.029.13-2.64
Cuorips Inc23.10m-632.18m23.66bn46.00--3.95--1,024.04-86.04-86.043.14752.260.00474.6617.57---12.94---13.30--41.69---2,736.49--33.80-------39.65---39.84------
Pharma Foods International Co., Ltd.65.08bn4.76bn25.15bn670.005.242.644.680.3865165.17165.172,257.80327.801.842.2212.7197,135,820.0013.448.4048.1219.2079.8981.347.323.850.844991.330.683928.2613.9453.90923.8057.9251.63--
StemRIM Inc2.35bn179.40m27.80bn44.00132.042.83--11.83-0.1097-0.109737.43159.710.2453----53,409,090.001.87-6.711.89-6.83----7.63-45.8078.90652.720.00--10,128.0663.68108.64------
Mizuho Medy Co Ltd11.34bn4.00bn32.48bn180.008.122.127.752.86419.74419.741,190.621,607.770.64841.872.9962,999,830.0022.8631.4626.2339.7873.4174.8535.2533.646.41--0.0034.83-37.4911.34-51.8532.64-17.7432.85
SanBio Co Ltd0.00-2.64bn32.74bn29.00--11.60-----40.50-40.500.0041.110.00----0.00-43.74-42.00-52.38-48.88-------4,790.72----0.1923------52.44--53.94--
Koa Shoji Holdings Co Ltd22.67bn2.87bn34.43bn297.0011.991.529.611.5272.4572.45572.11573.530.78785.562.6276,317,420.009.987.9112.089.9329.9528.7412.6610.483.8636.550.114219.648.358.2713.9029.60-21.2615.52
Daito Pharmaceutical Co Ltd45.19bn3.28bn36.00bn1.01k11.030.69245.300.7965207.85207.852,864.813,311.810.61931.812.6544,701,280.004.356.995.649.2921.3822.717.038.831.15--0.123117.083.772.49-22.883.437.4812.70
Fuji Pharma Co Ltd43.05bn5.92bn36.71bn1.62k6.090.81833.990.8527243.57243.571,771.381,812.380.50711.343.2126,558,910.006.974.1010.565.5839.7842.4113.757.550.5895--0.382631.1715.421.5227.410.370919.045.73
Seikagaku Corp36.21bn2.19bn43.63bn976.0019.160.579711.201.2040.0840.08663.801,324.810.46012.065.02--2.780.42613.050.467846.6054.186.040.98144.47--0.0055415.528.244.99-2.24-0.522430.280.00
Data as of May 24 2024. Currency figures normalised to Koa Shoji Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

5.06%Per cent of shares held by top holders
HolderShares% Held
SBI Asset Management Co., Ltd.as of 22 Jul 2022839.70k2.12%
Nomura Asset Management Co., Ltd.as of 30 Apr 2024486.00k1.23%
Nikko Asset Management Co., Ltd.as of 10 May 2024218.50k0.55%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024205.60k0.52%
Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 202491.30k0.23%
Dimensional Fund Advisors LPas of 09 May 202457.60k0.15%
BlackRock Japan Co. Ltd.as of 09 May 202440.10k0.10%
Acadian Asset Management LLCas of 31 Mar 202423.70k0.06%
Mandarine Gestion SAas of 29 Feb 202422.50k0.06%
Asset Management One Co., Ltd.as of 09 May 202420.00k0.05%
More ▼
Data from 22 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.